investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
Epidemiologic factors and survival by molecular subtypes of ovarian cancer
Mary Anne Rossing
0 Collaborator(s)
Funding source
National Institutes of Health (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
Mary Anne Rossing
Fred Hutchinson Cancer Research Center
Seattle, United States
Related projects
Carlo M Croce
MiRNAs/UCRs: Biomarkers for Cancer Risk, Tumor Detection, Progression and Treatment
Ovary
Kylie Walters
Ubiquitin Signaling
Ovary
Pathology
Shahinaz Gadalla
Myotonic Dystrophy Tumorigenesis: Risk Factors and Molecular Mechanisms
Ovary
Brahm H Segal
Novel immunological biomarkers ovarian cancer prognosis
Ovary
Kevin Hasegawa Eng
Informatic Methods for Differential Signaling and Immune Co-Regulatory Expression
Ovary
Bryan Q Spring
Online monitoring and image-guided treatment of chemoresistant micrometastases
Ovary
Pathology
Ram Prasad
Nanoprobe-amplified spectroscopic assay for accurate assessment of ovarian cancer burden in peripheral blood
Ovary
Pathology
Catherine Phelan
The Mitochondrial Genome and Ovarian Cancer Risk
Ovary
Pathology
Martin Mcintosh
Profiling cancer neoantigen repertoires and validating immunotherapy targets
Ovary